Management von Anaphylaxie-gefährdeten Patienten während der Covid-19-Pandemie
- 9 November 2020
- journal article
- research article
- Published by Springer Nature in Allergo Journal
- Vol. 29 (7) , 16-26
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Guideline for acute therapy and management of anaphylaxisAllergo Journal International, 2014
- World Allergy Organization Anaphylaxis Guidelines: 2013 Update of the Evidence BaseInternational Archives of Allergy and Immunology, 2013
- Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest GroupAllergy, 2013
- Anaphylaxis in an emergency setting – elicitors, therapy and incidence of severe allergic reactionsAllergy, 2012
- Innate and adaptive immune responses to viral infection and vaccinationCurrent Opinion in Virology, 2011
- General considerations on rapid desensitization for drug hypersensitivity – a consensus statementAllergy, 2010
- Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database reviewJournal of Allergy and Clinical Immunology, 2010
- A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preferenceAnnals of Allergy, Asthma & Immunology, 2010
- Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy OrganizationAllergy, 2008
- Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and AdolescentsNew England Journal of Medicine, 1992